Lack of Effectiveness of Bebtelovimab Monoclonal Antibody among High-Risk Patients with SARS-Cov-2 Omicron During BA.2, BA.2.12.1 and BA.5 Subvariants Dominated Era.
PLOS ONE（2023）
Key words
Corona Virus
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined